Effectiveness of 8-Week Glecaprevir/Pibrentasvir for Treatment-Naïve, Compensated Cirrhotic Patients With Chronic Hepatitis C Infection

Advances in Therapy - United States
doi 10.1007/s12325-020-01301-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC